Retour

Liquidia Corp executive sells over $14k in company stock - Investing.com

News Liquidia Corp

Liquidia Corp's Chief Business Officer Jason Adair sold over $14,000 worth of company stock, citing the need to cover taxes associated with the vesting of restricted stock units. The transaction was conducted under a pre-arranged trading plan, and Adair still maintains a significant investment in the company.

Investing.com • 16/07/2024 à 00:47:39
Liquidia Corporation Common Stock
Adresse: 419 DAVIS DRIVE, SUITE 100
Code postal: 27560
Ville: MORRISVILLE
Region: NC
Numéro de telephone: 919.328.4400
Site internet: https://www.liquidia.com
Status: Active
Info de l'entreprise

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Date de référencement2018-07-26
MarchéStocks
LocaleUS
Echange principalXNAS
TypeCS
DeviseUSD
CIK0001819576
Composite figiBBG001J2P905
Share Class figiBBG001V0GFD7
Market Cap698,438,647 USD
SIC Code2834
SIC DescriptionPHARMACEUTICAL PREPARATIONS
Total Employés145
Share Class Shares Outstanding76790000
Weighted Shares Outstanding76793694
Round Lot100
Date de mise à jour2024-09-07
Stats
Historique
PériodeVarPlus hautPlus bas
1 semaine
-3.36%
9.609
9.157
1 mois
-14.2%
11.539
9.157
3 mois
-32.77%
13.855
9.157
6 mois
-33.84%
14.33
9.157
1 an
29.62%
7.14
5.71
3 ans
239.11%
2.7878
2.52
5 ans
130.33%
4.055
2.25
10 ans
-26.18%
13.43
2.25
Actions
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-08 2023-08-10 2023-11-07 UNPUB
Assets 128,922,000 121,597,000 111,641,000 UNPUB
Current Assets 99,690,000 92,892,000 82,980,000 UNPUB
Current Liabilities 6,820,000 19,495,000 12,156,000 UNPUB
Equity 81,643,000 60,657,000 48,006,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 81,643,000 60,657,000 48,006,000 UNPUB
Liabilities 47,279,000 60,940,000 63,635,000 UNPUB
Liabilities And Equity 128,922,000 121,597,000 111,641,000 UNPUB
Noncurrent Assets 29,232,000 28,705,000 28,661,000 UNPUB
Noncurrent Liabilities 40,459,000 41,445,000 51,479,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-08 2023-08-10 2023-11-07 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 1,129,000 -6,216,000 -11,971,000 UNPUB
Net Cash Flow, Continuing 1,129,000 -6,216,000 -11,971,000 UNPUB
Net Cash Flow From Financing Activities 9,950,000 -409,000 10,065,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 9,950,000 -409,000 10,065,000 UNPUB
Net Cash Flow From Investing Activities -364,000 -243,000 -10,475,000 UNPUB
Net Cash Flow From Investing Activities, Continuing -364,000 -243,000 -10,475,000 UNPUB
Net Cash Flow From Operating Activities -8,457,000 -5,564,000 -11,561,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -8,457,000 -5,564,000 -11,561,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-08 2023-08-10 2023-11-07 UNPUB
Comprehensive Income/Loss -11,745,000 -23,517,000 -15,790,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -11,745,000 -23,517,000 -15,790,000 UNPUB
Other Comprehensive Income/Loss 0 0 0 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-08 2023-08-10 2023-11-07 UNPUB
Basic Earnings Per Share 0 0 0 UNPUB
Benefits Costs and Expenses 16,238,000 27,611,000 18,569,000 UNPUB
Cost Of Revenue 654,000 671,000 570,000 UNPUB
Costs And Expenses 13,725,000 27,611,000 18,569,000 UNPUB
Diluted Earnings Per Share 0 0 0 UNPUB
Gross Profit 3,839,000 4,115,000 3,108,000 UNPUB
Income/Loss From Continuing Operations After Tax -11,745,000 -23,517,000 -15,790,000 UNPUB
Income/Loss From Continuing Operations Before Tax -11,745,000 -22,825,000 -14,891,000 UNPUB
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 1,124,000 1,426,000 1,761,000 UNPUB
Net Income/Loss -11,745,000 -23,517,000 -15,790,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -11,745,000 -23,517,000 -15,790,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -11,745,000 -23,517,000 -15,790,000 UNPUB
Operating Expenses 13,071,000 26,940,000 17,999,000 UNPUB
Operating Income/Loss -9,232,000 -22,825,000 -14,891,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 4,493,000 4,786,000 3,678,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-08 2023-03-20
Assets 93,525,000 139,082,000 132,568,000 129,198,000
Current Assets 61,955,000 108,500,000 103,058,000 99,811,000
Current Liabilities 7,976,000 6,837,000 7,460,000 8,800,000
Equity 55,389,000 102,107,000 95,034,000 90,422,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 55,389,000 102,107,000 95,034,000 90,422,000
Liabilities 38,136,000 36,975,000 37,534,000 38,776,000
Liabilities And Equity 93,525,000 139,082,000 132,568,000 129,198,000
Noncurrent Assets 31,570,000 30,582,000 29,510,000 29,387,000
Noncurrent Liabilities 0 0 30,074,000 29,976,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-08 2023-03-20
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 46,346,000 -5,520,000 35,789,000
Net Cash Flow, Continuing 0 46,346,000 -5,520,000 35,789,000
Net Cash Flow From Financing Activities 10,082,000 54,477,000 348,000 64,964,000
Net Cash Flow From Financing Activities, Continuing 10,082,000 54,477,000 348,000 64,964,000
Net Cash Flow From Investing Activities -300,000 298,000 -94,000 -587,000
Net Cash Flow From Investing Activities, Continuing -300,000 298,000 -94,000 -587,000
Net Cash Flow From Operating Activities -9,782,000 -8,429,000 -5,774,000 -28,588,000
Net Cash Flow From Operating Activities, Continuing -9,782,000 -8,429,000 -5,774,000 -28,588,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-08 2023-03-20
Comprehensive Income/Loss -15,943,000 -9,447,000 -9,092,000 -41,015,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -15,943,000 -9,447,000 -9,092,000 -41,015,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-08 2023-03-20
Basic Earnings Per Share 0 0 0 -1
Benefits Costs and Expenses 19,435,000 12,888,000 11,996,000 56,950,000
Cost Of Revenue 694,000 731,000 740,000 2,859,000
Costs And Expenses 17,964,000 12,888,000 11,996,000 54,705,000
Diluted Earnings Per Share 0 0 0 -1
Gross Profit 2,798,000 3,187,000 2,425,000 13,076,000
Income/Loss From Continuing Operations After Tax -15,943,000 -9,447,000 -9,092,000 -41,015,000
Income/Loss From Continuing Operations Before Tax -15,943,000 -9,447,000 -8,831,000 -41,015,000
Income Tax Expense/Benefit 0 UNPUB UNPUB 0
Interest Expense, Operating 478,000 542,000 620,000 2,338,000
Net Income/Loss -15,943,000 -9,447,000 -9,092,000 -41,015,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -15,943,000 -9,447,000 -9,092,000 -41,015,000
Net Income/Loss Available To Common Stockholders, Basic -15,943,000 -9,447,000 -9,092,000 -41,015,000
Operating Expenses 17,270,000 12,157,000 11,256,000 51,846,000
Operating Income/Loss -14,472,000 -8,970,000 -8,831,000 -38,770,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 3,492,000 3,918,000 3,165,000 15,935,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-10 2021-11-03 2022-03-17
Assets 88,451,874 104,381,689 100,299,409 93,729,219
Current Assets 55,078,801 71,320,562 67,479,874 61,276,031
Current Liabilities 7,882,857 6,972,938 7,064,392 7,326,795
Equity 62,909,179 79,020,857 72,964,009 65,265,541
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 62,909,179 79,020,857 72,964,009 65,265,541
Liabilities 25,542,695 25,360,832 27,335,400 28,463,678
Liabilities And Equity 88,451,874 104,381,689 100,299,409 93,729,219
Noncurrent Assets 33,373,073 33,061,127 32,819,535 32,453,188
Noncurrent Liabilities 0 0 20,271,008 21,136,883
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-10 2021-11-03 2022-03-17
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -11,679,326 14,252,339 -3,835,699 -7,822,548
Net Cash Flow, Continuing -11,679,326 14,252,339 -3,835,699 -7,822,548
Net Cash Flow From Financing Activities 758,813 22,547,355 1,994,717 26,320,331
Net Cash Flow From Financing Activities, Continuing 758,813 22,547,355 1,994,717 26,320,331
Net Cash Flow From Investing Activities -52,419 -34,821 0 -107,220
Net Cash Flow From Investing Activities, Continuing -52,419 -34,821 0 -107,220
Net Cash Flow From Operating Activities -12,385,720 -8,260,195 -5,830,416 -34,035,659
Net Cash Flow From Operating Activities, Continuing -12,385,720 -8,260,195 -5,830,416 -34,035,659
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-10 2021-11-03 2022-03-17
Comprehensive Income/Loss -9,183,153 -6,551,486 -7,280,892 -34,578,648
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -9,183,153 -6,551,486 -7,280,892 -34,578,648
Other Comprehensive Income/Loss 0 0 -7,280,892 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-13 2021-08-10 2021-11-03 2022-03-17
Basic Earnings Per Share UNPUB UNPUB UNPUB -1
Benefits Costs and Expenses 12,084,714 9,729,944 10,258,278 47,431,993
Cost Of Revenue 693,735 713,736 889,511 3,022,911
Costs And Expenses 12,084,714 9,729,944 10,258,278 46,650,388
Diluted Earnings Per Share UNPUB UNPUB UNPUB -1
Gross Profit 2,389,896 2,662,350 2,289,110 9,830,434
Income/Loss From Continuing Operations After Tax -9,183,153 -6,551,486 -7,280,892 -34,578,648
Income/Loss From Continuing Operations Before Tax -9,183,153 -6,551,486 -7,079,657 -34,578,648
Income Tax Expense/Benefit 0 0 0 0
Interest Expense, Operating 202,836 202,508 205,110 815,040
Net Income/Loss -9,183,153 -6,551,486 -7,280,892 -34,578,648
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -9,183,153 -6,551,486 -7,280,892 -34,578,648
Net Income/Loss Available To Common Stockholders, Basic -9,183,153 -6,551,486 -7,280,892 -34,578,648
Operating Expenses 11,390,979 9,016,208 9,368,767 43,627,477
Operating Income/Loss -9,001,083 -6,353,858 -7,079,657 -33,797,043
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 3,083,631 3,376,086 3,178,621 12,853,345
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2021-03-25
Assets UNPUB UNPUB UNPUB 99,531,760
Current Assets UNPUB UNPUB UNPUB 66,068,928
Current Liabilities UNPUB UNPUB UNPUB 11,737,374
Equity UNPUB UNPUB UNPUB 71,085,838
Equity Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Equity Attributable To Parent UNPUB UNPUB UNPUB 71,085,838
Liabilities UNPUB UNPUB UNPUB 28,445,922
Liabilities And Equity UNPUB UNPUB UNPUB 99,531,760
Noncurrent Assets UNPUB UNPUB UNPUB 33,462,832
Noncurrent Liabilities UNPUB UNPUB UNPUB 16,708,548
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2021-03-25
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB UNPUB 9,520,103
Net Cash Flow, Continuing UNPUB UNPUB UNPUB 9,520,103
Net Cash Flow From Financing Activities UNPUB UNPUB UNPUB 63,416,696
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB UNPUB 63,416,696
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB 247,914
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB 247,914
Net Cash Flow From Operating Activities UNPUB UNPUB UNPUB -54,144,507
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB UNPUB -54,144,507
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2021-03-25
Comprehensive Income/Loss UNPUB UNPUB UNPUB -59,762,769
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -59,762,769
Other Comprehensive Income/Loss UNPUB UNPUB UNPUB 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2021-03-25
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB 59,828,758
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB 59,828,758
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB UNPUB UNPUB -59,762,769
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB UNPUB -59,089,130
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB 857,998
Net Income/Loss UNPUB UNPUB UNPUB -59,762,769
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Net Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -59,762,769
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB UNPUB -59,762,769
Operating Expenses UNPUB UNPUB UNPUB 59,828,758
Operating Income/Loss UNPUB UNPUB UNPUB -59,089,130
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB UNPUB 0
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB UNPUB 0
Revenues UNPUB UNPUB UNPUB 739,628
Calendrier économique
6 Septembre 2024 (heure UTC) Actuel Précédent Consensus
★
15:30
United States
SEP 03
-27700.000
-32700.000
★
15:30
United States
SEP 03
46100.000
52200.000
★
15:30
United States
SEP 03
-48800.000
-81900.000
★
15:30
United States
SEP 03
-100300.000
-92200.000
★★
15:30
United States
SEP 03
26000.000
21400.000
★
15:30
United States
SEP 03
287600.000
294400.000
★
15:30
United States
SEP 03
177000.000
226700.000
★
15:30
United States
SEP 03
-90500.000
-148500.000
★
15:30
United States
SEP 03
-162000.000
-184300.000
★
15:30
United States
SEP 03
13000.000
17100.000
★
15:30
United States
SEP 03
2300.000
2200.000
★
15:30
United States
★
15:30
United States
★★
15:30
United States
★
15:30
United States
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:LQDA240719P00030000 OPASPS Put American 100 30 BATO 2024-07-19
O:LQDA240719C00030000 OCASPS Call American 100 30 BATO 2024-07-19
O:LQDA240719P00025000 OPASPS Put American 100 25 BATO 2024-07-19
O:LQDA240719C00025000 OCASPS Call American 100 25 BATO 2024-07-19
O:LQDA240719P00022500 OPASPS Put American 100 22.5 BATO 2024-07-19
O:LQDA240719P00020000 OPASPS Put American 100 20 BATO 2024-07-19
O:LQDA240719P00017500 OPASPS Put American 100 17.5 BATO 2024-07-19
O:LQDA240719P00015000 OPASPS Put American 100 15 BATO 2024-07-19
O:LQDA240719P00012500 OPASPS Put American 100 12.5 BATO 2024-07-19
O:LQDA240719C00022500 OCASPS Call American 100 22.5 BATO 2024-07-19
O:LQDA240719P00010000 OPASPS Put American 100 10 BATO 2024-07-19
O:LQDA240719C00020000 OCASPS Call American 100 20 BATO 2024-07-19
O:LQDA240719P00007500 OPASPS Put American 100 7.5 BATO 2024-07-19
O:LQDA240719C00017500 OCASPS Call American 100 17.5 BATO 2024-07-19
O:LQDA240719P00005000 OPASPS Put American 100 5 BATO 2024-07-19
O:LQDA240719C00015000 OCASPS Call American 100 15 BATO 2024-07-19
O:LQDA240719P00002500 OPASPS Put American 100 2.5 BATO 2024-07-19
O:LQDA240719C00012500 OCASPS Call American 100 12.5 BATO 2024-07-19
O:LQDA240719C00010000 OCASPS Call American 100 10 BATO 2024-07-19
O:LQDA240719C00007500 OCASPS Call American 100 7.5 BATO 2024-07-19
O:LQDA240719C00005000 OCASPS Call American 100 5 BATO 2024-07-19
O:LQDA240719C00002500 OCASPS Call American 100 2.5 BATO 2024-07-19
O:LQDA240621C00005000 OCASPS Call American 100 5 BATO 2024-06-21
O:LQDA240621C00002500 OCASPS Call American 100 2.5 BATO 2024-06-21
O:LQDA240621P00025000 OPASPS Put American 100 25 BATO 2024-06-21
O:LQDA240621P00022500 OPASPS Put American 100 22.5 BATO 2024-06-21
O:LQDA240621P00020000 OPASPS Put American 100 20 BATO 2024-06-21
O:LQDA240621P00017500 OPASPS Put American 100 17.5 BATO 2024-06-21
O:LQDA240621P00015000 OPASPS Put American 100 15 BATO 2024-06-21
O:LQDA240621P00012500 OPASPS Put American 100 12.5 BATO 2024-06-21
O:LQDA240621P00010000 OPASPS Put American 100 10 BATO 2024-06-21
O:LQDA240621P00007500 OPASPS Put American 100 7.5 BATO 2024-06-21
O:LQDA240621P00005000 OPASPS Put American 100 5 BATO 2024-06-21
O:LQDA240621P00002500 OPASPS Put American 100 2.5 BATO 2024-06-21
O:LQDA240621C00025000 OCASPS Call American 100 25 BATO 2024-06-21
O:LQDA240621C00022500 OCASPS Call American 100 22.5 BATO 2024-06-21
O:LQDA240621C00020000 OCASPS Call American 100 20 BATO 2024-06-21
O:LQDA240621C00017500 OCASPS Call American 100 17.5 BATO 2024-06-21
O:LQDA240621C00015000 OCASPS Call American 100 15 BATO 2024-06-21
O:LQDA240621C00012500 OCASPS Call American 100 12.5 BATO 2024-06-21
O:LQDA240621C00010000 OCASPS Call American 100 10 BATO 2024-06-21
O:LQDA240621C00007500 OCASPS Call American 100 7.5 BATO 2024-06-21
O:LQDA240517P00010000 OPASPS Put American 100 10 BATO 2024-05-17
O:LQDA240517P00007500 OPASPS Put American 100 7.5 BATO 2024-05-17
O:LQDA240517P00005000 OPASPS Put American 100 5 BATO 2024-05-17
O:LQDA240517P00002500 OPASPS Put American 100 2.5 BATO 2024-05-17
O:LQDA240517C00025000 OCASPS Call American 100 25 BATO 2024-05-17
O:LQDA240517C00022500 OCASPS Call American 100 22.5 BATO 2024-05-17
O:LQDA240517C00020000 OCASPS Call American 100 20 BATO 2024-05-17
O:LQDA240517C00017500 OCASPS Call American 100 17.5 BATO 2024-05-17
O:LQDA240517C00015000 OCASPS Call American 100 15 BATO 2024-05-17
O:LQDA240517C00012500 OCASPS Call American 100 12.5 BATO 2024-05-17
O:LQDA240517C00010000 OCASPS Call American 100 10 BATO 2024-05-17
O:LQDA240517C00007500 OCASPS Call American 100 7.5 BATO 2024-05-17
O:LQDA240517C00005000 OCASPS Call American 100 5 BATO 2024-05-17
O:LQDA240517C00002500 OCASPS Call American 100 2.5 BATO 2024-05-17
O:LQDA240517P00025000 OPASPS Put American 100 25 BATO 2024-05-17
O:LQDA240517P00022500 OPASPS Put American 100 22.5 BATO 2024-05-17
O:LQDA240517P00020000 OPASPS Put American 100 20 BATO 2024-05-17
O:LQDA240517P00017500 OPASPS Put American 100 17.5 BATO 2024-05-17
O:LQDA240517P00015000 OPASPS Put American 100 15 BATO 2024-05-17
O:LQDA240517P00012500 OPASPS Put American 100 12.5 BATO 2024-05-17
O:LQDA240419P00012500 OPASPS Put American 100 12.5 BATO 2024-04-19
O:LQDA240419P00010000 OPASPS Put American 100 10 BATO 2024-04-19
O:LQDA240419P00007500 OPASPS Put American 100 7.5 BATO 2024-04-19
O:LQDA240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:LQDA240419P00002500 OPASPS Put American 100 2.5 BATO 2024-04-19
O:LQDA240419C00012500 OCASPS Call American 100 12.5 BATO 2024-04-19
O:LQDA240419C00010000 OCASPS Call American 100 10 BATO 2024-04-19
O:LQDA240419C00007500 OCASPS Call American 100 7.5 BATO 2024-04-19
O:LQDA240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:LQDA240419C00002500 OCASPS Call American 100 2.5 BATO 2024-04-19
O:LQDA240419P00025000 OPASPS Put American 100 25 BATO 2024-04-19
O:LQDA240419P00022500 OPASPS Put American 100 22.5 BATO 2024-04-19
O:LQDA240419P00020000 OPASPS Put American 100 20 BATO 2024-04-19
O:LQDA240419P00017500 OPASPS Put American 100 17.5 BATO 2024-04-19
O:LQDA240419P00015000 OPASPS Put American 100 15 BATO 2024-04-19
O:LQDA240419C00025000 OCASPS Call American 100 25 BATO 2024-04-19
O:LQDA240419C00022500 OCASPS Call American 100 22.5 BATO 2024-04-19
O:LQDA240419C00020000 OCASPS Call American 100 20 BATO 2024-04-19
O:LQDA240419C00017500 OCASPS Call American 100 17.5 BATO 2024-04-19
O:LQDA240419C00015000 OCASPS Call American 100 15 BATO 2024-04-19
O:LQDA240315P00025000 OPASPS Put American 100 25 BATO 2024-03-15
O:LQDA240315P00022500 OPASPS Put American 100 22.5 BATO 2024-03-15
O:LQDA240315P00020000 OPASPS Put American 100 20 BATO 2024-03-15
O:LQDA240315P00017500 OPASPS Put American 100 17.5 BATO 2024-03-15
O:LQDA240315P00015000 OPASPS Put American 100 15 BATO 2024-03-15
O:LQDA240315P00012500 OPASPS Put American 100 12.5 BATO 2024-03-15
O:LQDA240315P00010000 OPASPS Put American 100 10 BATO 2024-03-15
O:LQDA240315P00007500 OPASPS Put American 100 7.5 BATO 2024-03-15
O:LQDA240315P00005000 OPASPS Put American 100 5 BATO 2024-03-15
O:LQDA240315P00002500 OPASPS Put American 100 2.5 BATO 2024-03-15
O:LQDA240315C00025000 OCASPS Call American 100 25 BATO 2024-03-15
O:LQDA240315C00022500 OCASPS Call American 100 22.5 BATO 2024-03-15
O:LQDA240315C00020000 OCASPS Call American 100 20 BATO 2024-03-15
O:LQDA240315C00017500 OCASPS Call American 100 17.5 BATO 2024-03-15
O:LQDA240315C00015000 OCASPS Call American 100 15 BATO 2024-03-15
O:LQDA240315C00012500 OCASPS Call American 100 12.5 BATO 2024-03-15
O:LQDA240315C00010000 OCASPS Call American 100 10 BATO 2024-03-15
O:LQDA240315C00007500 OCASPS Call American 100 7.5 BATO 2024-03-15
O:LQDA240315C00005000 OCASPS Call American 100 5 BATO 2024-03-15
O:LQDA240315C00002500 OCASPS Call American 100 2.5 BATO 2024-03-15
O:LQDA240216P00022500 OPASPS Put American 100 22.5 BATO 2024-02-16
O:LQDA240216P00020000 OPASPS Put American 100 20 BATO 2024-02-16
O:LQDA240216P00017500 OPASPS Put American 100 17.5 BATO 2024-02-16
O:LQDA240216P00015000 OPASPS Put American 100 15 BATO 2024-02-16
O:LQDA240216P00012500 OPASPS Put American 100 12.5 BATO 2024-02-16
O:LQDA240216P00010000 OPASPS Put American 100 10 BATO 2024-02-16
O:LQDA240216P00007500 OPASPS Put American 100 7.5 BATO 2024-02-16
O:LQDA240216P00005000 OPASPS Put American 100 5 BATO 2024-02-16
O:LQDA240216P00002500 OPASPS Put American 100 2.5 BATO 2024-02-16
O:LQDA240216C00022500 OCASPS Call American 100 22.5 BATO 2024-02-16
O:LQDA240216C00020000 OCASPS Call American 100 20 BATO 2024-02-16
O:LQDA240216C00017500 OCASPS Call American 100 17.5 BATO 2024-02-16
O:LQDA240216C00015000 OCASPS Call American 100 15 BATO 2024-02-16
O:LQDA240216C00012500 OCASPS Call American 100 12.5 BATO 2024-02-16
O:LQDA240216C00010000 OCASPS Call American 100 10 BATO 2024-02-16
O:LQDA240216C00007500 OCASPS Call American 100 7.5 BATO 2024-02-16
O:LQDA240216C00005000 OCASPS Call American 100 5 BATO 2024-02-16
O:LQDA240216C00002500 OCASPS Call American 100 2.5 BATO 2024-02-16
O:LQDA240119P00017500 OPASPS Put American 100 17.5 BATO 2024-01-19
O:LQDA240119P00015000 OPASPS Put American 100 15 BATO 2024-01-19
O:LQDA240119P00012500 OPASPS Put American 100 12.5 BATO 2024-01-19
O:LQDA240119P00010000 OPASPS Put American 100 10 BATO 2024-01-19
O:LQDA240119P00022500 OPASPS Put American 100 22.5 BATO 2024-01-19
O:LQDA240119P00007500 OPASPS Put American 100 7.5 BATO 2024-01-19
O:LQDA240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:LQDA240119P00020000 OPASPS Put American 100 20 BATO 2024-01-19
O:LQDA240119P00002500 OPASPS Put American 100 2.5 BATO 2024-01-19
O:LQDA240119C00017500 OCASPS Call American 100 17.5 BATO 2024-01-19
O:LQDA240119C00015000 OCASPS Call American 100 15 BATO 2024-01-19
O:LQDA240119C00022500 OCASPS Call American 100 22.5 BATO 2024-01-19
O:LQDA240119C00012500 OCASPS Call American 100 12.5 BATO 2024-01-19
O:LQDA240119C00010000 OCASPS Call American 100 10 BATO 2024-01-19
O:LQDA240119C00020000 OCASPS Call American 100 20 BATO 2024-01-19
O:LQDA240119C00007500 OCASPS Call American 100 7.5 BATO 2024-01-19
O:LQDA240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:LQDA240119C00002500 OCASPS Call American 100 2.5 BATO 2024-01-19
O:LQDA231215P00010000 OPASPS Put American 100 10 BATO 2023-12-15
O:LQDA231215P00007500 OPASPS Put American 100 7.5 BATO 2023-12-15
O:LQDA231215P00005000 OPASPS Put American 100 5 BATO 2023-12-15
O:LQDA231215P00002500 OPASPS Put American 100 2.5 BATO 2023-12-15
O:LQDA231215C00010000 OCASPS Call American 100 10 BATO 2023-12-15
O:LQDA231215C00007500 OCASPS Call American 100 7.5 BATO 2023-12-15
O:LQDA231215C00005000 OCASPS Call American 100 5 BATO 2023-12-15
O:LQDA231215C00002500 OCASPS Call American 100 2.5 BATO 2023-12-15
O:LQDA231117P00012500 OPASPS Put American 100 12.5 BATO 2023-11-17
O:LQDA231117P00010000 OPASPS Put American 100 10 BATO 2023-11-17
O:LQDA231117P00007500 OPASPS Put American 100 7.5 BATO 2023-11-17
O:LQDA231117P00005000 OPASPS Put American 100 5 BATO 2023-11-17
O:LQDA231117P00002500 OPASPS Put American 100 2.5 BATO 2023-11-17
O:LQDA231117C00012500 OCASPS Call American 100 12.5 BATO 2023-11-17
O:LQDA231117C00010000 OCASPS Call American 100 10 BATO 2023-11-17
O:LQDA231117C00007500 OCASPS Call American 100 7.5 BATO 2023-11-17
O:LQDA231117C00005000 OCASPS Call American 100 5 BATO 2023-11-17
O:LQDA231117C00002500 OCASPS Call American 100 2.5 BATO 2023-11-17
O:LQDA231020P00017500 OPASPS Put American 100 17.5 BATO 2023-10-20
O:LQDA231020P00015000 OPASPS Put American 100 15 BATO 2023-10-20
O:LQDA231020P00012500 OPASPS Put American 100 12.5 BATO 2023-10-20
O:LQDA231020P00010000 OPASPS Put American 100 10 BATO 2023-10-20
O:LQDA231020P00007500 OPASPS Put American 100 7.5 BATO 2023-10-20
O:LQDA231020P00005000 OPASPS Put American 100 5 BATO 2023-10-20
O:LQDA231020P00002500 OPASPS Put American 100 2.5 BATO 2023-10-20
O:LQDA231020C00017500 OCASPS Call American 100 17.5 BATO 2023-10-20
O:LQDA231020C00015000 OCASPS Call American 100 15 BATO 2023-10-20
O:LQDA231020C00012500 OCASPS Call American 100 12.5 BATO 2023-10-20
O:LQDA231020C00010000 OCASPS Call American 100 10 BATO 2023-10-20
O:LQDA231020C00007500 OCASPS Call American 100 7.5 BATO 2023-10-20
O:LQDA231020C00005000 OCASPS Call American 100 5 BATO 2023-10-20
O:LQDA231020C00002500 OCASPS Call American 100 2.5 BATO 2023-10-20
O:LQDA230915P00015000 OPASPS Put American 100 15 BATO 2023-09-15
O:LQDA230915P00012500 OPASPS Put American 100 12.5 BATO 2023-09-15
O:LQDA230915P00010000 OPASPS Put American 100 10 BATO 2023-09-15
O:LQDA230915P00007500 OPASPS Put American 100 7.5 BATO 2023-09-15
O:LQDA230915P00005000 OPASPS Put American 100 5 BATO 2023-09-15
O:LQDA230915P00002500 OPASPS Put American 100 2.5 BATO 2023-09-15
O:LQDA230915C00015000 OCASPS Call American 100 15 BATO 2023-09-15
O:LQDA230915C00012500 OCASPS Call American 100 12.5 BATO 2023-09-15
O:LQDA230915C00010000 OCASPS Call American 100 10 BATO 2023-09-15
O:LQDA230915C00007500 OCASPS Call American 100 7.5 BATO 2023-09-15
O:LQDA230915C00005000 OCASPS Call American 100 5 BATO 2023-09-15
O:LQDA230915C00002500 OCASPS Call American 100 2.5 BATO 2023-09-15
O:LQDA230818P00015000 OPASPS Put American 100 15 BATO 2023-08-18
O:LQDA230818P00012500 OPASPS Put American 100 12.5 BATO 2023-08-18
O:LQDA230818P00010000 OPASPS Put American 100 10 BATO 2023-08-18
O:LQDA230818P00007500 OPASPS Put American 100 7.5 BATO 2023-08-18
O:LQDA230818P00005000 OPASPS Put American 100 5 BATO 2023-08-18
O:LQDA230818P00002500 OPASPS Put American 100 2.5 BATO 2023-08-18
O:LQDA230818C00015000 OCASPS Call American 100 15 BATO 2023-08-18
O:LQDA230818C00012500 OCASPS Call American 100 12.5 BATO 2023-08-18
O:LQDA230818C00010000 OCASPS Call American 100 10 BATO 2023-08-18
O:LQDA230818C00007500 OCASPS Call American 100 7.5 BATO 2023-08-18
O:LQDA230818C00005000 OCASPS Call American 100 5 BATO 2023-08-18
O:LQDA230818C00002500 OCASPS Call American 100 2.5 BATO 2023-08-18
Flux d'actualités
News Pulmonary Arterial Hypertension
La FDA américaine accorde une approbation provisoire à YUTREPIA™ (treprostinil) en poudre pour inhalation pour les patients souffrant d'hypertension artérielle pulmonaire (HTAP) et d'hypertension pulmonaire associée à une maladie pulmonaire interstitielle (PH-ILD).
La FDA américaine a accordé une autorisation provisoire à YUTREPIA (tréprostinil), la poudre pour inhalation de Liquidia, pour le traitement des adultes souffrant d'hypertension artérielle pulmonaire (HTAP) et d'hypertension pulmonaire associée à une maladie pulmonaire interstitielle (PH-ILD). Toutefois, l'approbation finale est retardée en raison de l'exclusivité réglementaire accordée à un produit concurrent.
GlobeNewswire Inc. • Il y a 2 semaines
News Liquidia Corp
Liquidia corp chief medical officer sells $18.4k in stock - Investing.com
Liquidia Corp's Chief Medical Officer, Rajeev Saggar, has sold 1,470 shares of the company's common stock for $18,419, pursuant to a pre-scheduled 10b5-1 trading plan. The sale was to cover taxes associated with the vesting of restricted stock units.
Investing.com • Il y a 1 mois
News Liquidia Corp
Liquidia Corp executive sells shares worth over $19,000 - Investing.com
Liquidia Corp's Chief Commercial Officer, Scott Moomaw, sold 1,528 shares of the company's common stock for around $19,145 under a Rule 10b5-1 trading plan. The sale was to cover tax obligations associated with the settlement of restricted stock units.
Investing.com • Il y a 1 mois
News Liquidia Corp
Voip-pal director Kevin Williams sells shares worth $19,234 By Investing.com - Investing.com
Liquidia Corp CEO Roger Jeffs sold over $100,000 worth of company stock, citing the need to cover taxes related to restricted stock units. The sale was part of a pre-arranged trading plan and does not necessarily indicate a change in the CEO's outlook on the company's prospects.
Investing.com • Il y a 1 mois
News Liquidia Corp
Liquidia Corp executive sells over $14k in company stock - Investing.com
Liquidia Corp's Chief Business Officer Jason Adair sold over $14,000 worth of company stock, citing the need to cover taxes associated with the vesting of restricted stock units. The transaction was conducted under a pre-arranged trading plan, and Adair still maintains a significant investment in the company.
Investing.com • Il y a 1 mois
Calendar Calendar of Events
Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)
MORRISVILLE, N.C., June 18, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today the company will present seven posters related to its product pipeline at the 7th World Symposia of Pulmonary Hypertension (WSPH) taking place June 29 to July 1, 2024, in Barcelona, Spain. The posters outlined below address the clinical investigations of Liquidia’s investigational products, YUTREPIA™ (treprostinil) inhalation powder and L606 (liposomal treprostinil) inhalation suspension sustained-release formulation to treat people with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
GlobeNewswire Inc. • Il y a 2 mois
Calendar Calendar of Events
Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD
Liquidia Corporation (NASDAQ: LQDA) announced today the company will present data at the American Thoracic Society (ATS) 2024 International Conference.
GlobeNewswire Inc. • Il y a 4 mois
Calendar Calendar of Events
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
MORRISVILLE, N.C., April 02, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) announced today that Dr. Roger Jeffs, Chief Executive Officer, and Micheal Kaseta, Chief Operating Officer and Chief Financial Officer, will provide an overview and update on the company's business during a fireside chat session at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024, beginning at 1:30 p.m. Eastern Time.
GlobeNewswire Inc. • Il y a 5 mois
Analyst Analyst Ratings
The Analyst Landscape: 5 Takes On Liquidia
Liquidia (NASDAQ:LQDA) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 5 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 2 0 0 0 0 2M Ago 1 0 0 0 0 3M Ago 1 0 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $28.8, a high estimate of $32.00, and a low estimate of $28.00. Observing a 39.33% increase, the current average has risen from the previous average price target of $20.67. Breaking Down Analyst Ratings: A Detailed Examination The standing of Liquidia among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Serge Belanger Needham Maintains Buy $28.00 - Andrew Fein HC Wainwright & Co. Raises Buy $32.00 $16.00 Serge Belanger Needham Maintains Buy $28.00 $28.00 Serge Belanger Needham Maintains Buy $28.00 - Serge Belanger Needham Raises Buy $28.00 $18.00 Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Liquidia. This information provides a snapshot of how analysts perceive the current state ...Full story available on Benzinga.com
Benzinga • Il y a 5 mois
Stocks Research Analysis and Reports
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
MORRISVILLE, N.C., April 01, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) announced today that on March 28, Judge Andrews of the U.S. District Court for the District of Delaware (District Court) has set aside the injunction that was issued in August 2022 in the lawsuit filed by United Therapeutics (UTHR) in Case No. 1:20-cv-00755-RGA (the Original Hatch-Waxman Litigation). As a result, the U.S. Food and Drug Administration (FDA) is no longer enjoined from issuing final approval of Liquidia’s New Drug Application (NDA) for YUTREPIA™ (treprostinil) inhalation powder.
GlobeNewswire Inc. • Il y a 5 mois
Voir tous
Actualités liées
Dernières actualités

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT